Meet Our Editorial Board Member Current Alzheimer Research, 2017, Vol. 14, No. 9 913 Meet Our Editorial Board Member

Dr. Giulio Maria Pasinetti Icahn School of Medicine at Mount Sinai New York, NY USA

Dr. Pasinetti, The Saunders Family Chair and Professor of , received an M.D. from the Milan University School of Medicine and a Ph.D. from the University of Milan. He is currently the Program Director of the NIH funded Mount Sinai Center for Molecular Integrative Neuroresilience and the Chief of the Brain Institute Center of Excellence for Novel Approaches to Neurodiagnostics and Neurotherapeutics. He received several academic awards including the prestigious Zenith and Temple awards from the Alzheimer's Association. He was awarded ''The Faculty Council Award'' for academic excellence at Mount Sinai School of Medicine and "The Charles Dana Alliance for Brain Research Award" from Dana Foundation, recognizing productivity and worldwide leadership in his field of expertise, which further emphasizes his standing as an academic role model.

SELECTED PUBLICATIONS:

[1] Pasinetti GM. Towards prevention and therapy of Alzheimer's disease. Mol Asp Med 43-44: 1-2 (2015). [2] Hao K, Di Narzo AF, Ho L, Luo W, Li S, Chen R, Li T, Dubner L, Pasinetti GM. Shared genetic etiology underlying Alzheimer's disease and . Mol Aspects Med 43-44: 66-76 (2015). [3] Wang D, Ho L, Faith J, Ono K, Janle EM, Lachcik PJ, et al. Role of intestinal microbiota in the generation of -derived phenolic acid medi- ated attenuation of Alzheimer's disease β- oligomerization. Mol Nutr Food Res 59(6): 1025-40 (2015). [4] Vidaurre OG, Haines JD, Katz Sand I, Adula KP, Huynh JL, McGraw CA, Zhang F, Varghese M, Sotirchos E, Bhargava P, Bandaru VV, Pasinetti G, Zhang W, Inglese M, Calabresi PA, Wu G, Miller AE, Haughey NJ, Lublin FD, Casaccia P. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain 137(Pt 8): 2271-86 (2014). [5] Wang J, Bi W, Cheng A, Freire D, Vempati P, Zhao W, Gong B, Janle EM, Chen TY, Ferruzzi MG, Schmeidler J, Ho L, Pasinetti GM. Targeting multiple pathogenic mechanisms with for the treatment of Alzheimer's disease-experimental approach and therapeutic implications. Front Aging Neurosci 6: 42 (2014). [6] Wang J, Gong B, Zhao W, Tang C, Varghese M, Nguyen T, Bi W, Bilski A, Begum S, Vempati P, Knable L, Ho L, Pasinetti GM. Epigenetic mecha- nisms linking diabetes and synaptic impairments. Diabetes 63(2): 645-54 (2014). [7] Wang J, Ferruzzi MG, Ho L, Blount J, Janle E, Gong B, Pan Y, Raftery D, Arrieta-Cruz I, Sharma V, Cooper B, Lobo J, Simon JE, Zhang C, Cheng A, Qian X, Ono K, Teplow D, Pavlides C, Dixon R, Pasinetti GM. Brain Targeting Proanthocyanidin Metabolites for Alzheimer’s Disease Treatment. J Neurosci. 32(15): 5144-50 (2012).

1875-5828/17 $58.00+.00 © 2017 Bentham Science Publishers